Business context and reporting period
NuCana plc, a UK-based foreign private issuer that files annual reports on Form 20-F, furnished this Form 6-K for September 2026. The filing reports an event dated September 30, 2026.
Key event
NuCana announced that the European Patent Office issued patent EP 3683225 covering the composition of matter of NUC-7738. The filing does not provide details about the patent’s claims, duration, or commercial implications. It refers to an attached press release, but that release’s contents are not included in the supplied text.
Financial results and changes
This filing contains no revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics, and no comparison with a prior period.
Outlook, risks, and filing details
No guidance, outlook, management commentary, or specific risks or contingencies are described in the supplied text. The report states that its information is incorporated by reference into specified Form F-3 and Form S-8 registration statements, subject to the filing’s stated terms. Exhibit 99.1 is identified as a press release and is described as furnished rather than filed for purposes of Exchange Act Section 18.
Important facts for investors to verify
- Review the full September 30, 2026 press release and the patent record for the scope, term, and relevant jurisdictions of EP 3683225.
- Check subsequent company disclosures for details on NUC-7738 and any implications of the patent for development or commercialization.
- Consult NuCana’s financial filings for current operating performance, liquidity, and financing needs; this 6-K provides no such information.